Merck Issues Year’s Biggest Euro Company Bond to Fund Millipore
AstraZeneca Takes Selective Approach for Emerging Markets
Cancer Costs More Than Doubled in 40-Year Fight
Drug Giants Lag Where Sales Boom, Study Says
Lilly Hit Hard in Warehouse Heist
Read the rest of this entry »
Posted in Industry Stories
Drug Helps Diabetics, Trial Finds
Lilly Buys Right to Underarm Lotion for Low Sex Drive
Posted in Industry Stories
FDA Turns Down Once-Weekly Byetta
FDA Issues Boxed Warning for ‘Poor Metabolisers’ of Plavix
OSI Pharmaceuticals, Inc. Board Rejects Astellas Pharma Inc. $3.5 Billion
Read the rest of this entry »
Posted in Industry Stories
Pfizer’s Sutent Fails in Breast Cancer Trials
Ipsen Signs Obesity Deal With Rhythm
Genentech Says Avastin Trial Did Not Meet Goal
FDA: No Clear Evidence Linking Bisphosphonates and Fractures
Read the rest of this entry »
Posted in Industry Stories
PhRMA Stagement About Accessing Online Health Information (3/9)
AstraZeneca Inks Branded Generics Pact with India’s Torrent
WebMD Launches Social Networking Venture (3/9)
Roche and Biogen Idec Decide to Suspend Ocrelizumab Treatment
Read the rest of this entry »
Posted in Industry Stories
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
Cellzome Announces Second Major Strategic Drug Discovery Alliance with
Botox (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults
Quantity vs. Quality: Long-Term Use of Bone-Building Osteoporosis Drugs
Read the rest of this entry »
Posted in Industry Stories
Sanofi and Merck Link Up To Form Animal Health Giant
Genmab Shares Sink As Cancer Drug Fails in Phase III Study
The Potential For Using Algae To Produce Human Therapeutic Proteins
Science World Charmed By Snake Venom
Read the rest of this entry »
Posted in Industry Stories
Roche Stops RA Drug Development After Deaths
Pfizer Brings Out Big Guns to Woo Ratiopharm
AstraZeneca Shares Fall After Setback for Colon Cancer Drug
Xenoport, Inc., Restructures to Focus on Key Programs; Includes An Overall Reduction of 50% of XenoPort’s Workforce
Read the rest of this entry »
Posted in Industry Stories
BMS Says Five New Drugs Will Soften the Blow of Plavix
Pfizer, Bristol-Myers Say Clot Drug Meets Goals
Common Osteoporosis Drugs Are Associated With a Decrease in Risk of Breast Cancer
Anavex Comments on Failure of Pfizer and Medivation’s Alzheimer’s Investigational Drug Dimebon
Posted in Industry Stories
Disappointment at Failure of Pfizer/Medivation’s Alzheimer’s Drug
Teva Regains Exclusivity on Merck Meds
Sanofi’s Cabazitaxel Improves Survival in Prostate Cancer Patients
75 Percent Of Drug Companies Formally Manage Investigator-Initiated Trials
Read the rest of this entry »
Posted in Industry Stories
SUBSCRIBE